Pacira BioSciences CEO Frank D. Lee shares three core tenants to improve biopharmaceutical company leadership, especially companies with products capable of disrupting an established therapeutic area.
Paul Romness had over two decades of experience as a public and policy affairs expert when his daughter’s best friend’s osteosarcoma diagnosis inspired a new career trajectory.
Life sciences companies face challenges transitioning from R&D to clinical trials due to outdated, fragmented technology systems that struggle to support the ...